GB202108828D0 - Novel cancer therapy - Google Patents

Novel cancer therapy

Info

Publication number: GB202108828D0
Authority: GB; United Kingdom
Prior art keywords: cancer therapy; novel cancer; novel; therapy; cancer
Prior art date: 2021-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB2108828.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Intelligent Omics Ltd

Original Assignee

Intelligent Omics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2021-06-18

Filing date

2021-06-18

Publication date

2021-08-04

2021-06-18 Application filed by Intelligent Omics Ltd filed Critical Intelligent Omics Ltd

2021-06-18 Priority to GBGB2108828.1A priority Critical patent/GB202108828D0/en

2021-08-04 Publication of GB202108828D0 publication Critical patent/GB202108828D0/en

Status Ceased legal-status Critical Current

Links

238000011275 oncology therapy Methods 0.000 title 1

GBGB2108828.1A 2021-06-18 2021-06-18 Novel cancer therapy Ceased GB202108828D0 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
GBGB2108828.1A GB202108828D0 (en)	2021-06-18	2021-06-18	Novel cancer therapy

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB2108828.1A GB202108828D0 (en)	2021-06-18	2021-06-18	Novel cancer therapy

Publications (1)

Publication Number	Publication Date
GB202108828D0 true GB202108828D0 (en)	2021-08-04

Family

ID=77050550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB2108828.1A Ceased GB202108828D0 (en)	2021-06-18	2021-06-18	Novel cancer therapy

Country Status (1)

Country	Link
GB (1)	GB202108828D0 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8788444B2 (en)	2008-10-20	2014-07-22	Nottingham Trent University	Data analysis method and system

2021
- 2021-06-18 GB GBGB2108828.1A patent/GB202108828D0/en not_active Ceased

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8788444B2 (en)	2008-10-20	2014-07-22	Nottingham Trent University	Data analysis method and system

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
"Bioreversible Carriers in Drug Design", 1987, AMERICAN PHARMACEUTICAL ASSOCIATION AND PERGAMON PRESS
"Remington's Pharmaceutical Sciences", 1995, MACK PUBLISHING CO., pages: 1447 - 1676
"Synthetic Biology, Part A, Methods in Enzymology", vol. 498, 2011, article "Synthetic Biology, Part B, Computer Aided Design and DNA Assembly", pages: 2 - 500
B. ROEJ. CRABTREEA. KAHN: "DNA Isolation and Sequencing: Essential Techniques", 1996, JOHN WILEY & SONS
D. M. J. LILLEYJ. E. DAHLBERG: "Methods of Enzymology: DNA Structure Part A: Synthesis and Physical Analysis of DNA Methods in Enzymology", 1992, ACADEMIC PRESS
DAVID R. ENGELKEJOHN J. ROSSI: "Methods in Enzymology", vol. 392, 2005, article "RNA Interference", pages: 1 - 454
GAHROUDI ET AL., FEBS LETT., vol. 414, 1997, pages 521 - 526
GONG ET AL., PATHOL ONCOL RES., vol. 18, no. 4, October 2012 (2012-10-01), pages 989 - 96
HAMERS-CASTERMAN ET AL.: "Nature", vol. 363, 1993, pages: 446 - 448
HIGUCHISTELLA: "A.C.S. Symposium Series", vol. 14, 1987, article "Pro-drugs as Novel Delivery Systems"
J. M. POLAKJAMES O'D. MCGEE: "Situ Hybridisation: Principles and Practice", 1984, OXFORD UNIVERSITY PRESS
M.R. GREENJ. SAMBROOK: "Molecular Cloning: A Laboratory Manual", 2012, COLD SPRING HARBOR LABORATORY PRESS
RAMOS-SEVILLANO ET AL., PLOS PATHOG, vol. 12, no. 3, 14 March 2016 (2016-03-14), pages e1005500
RIECHMANN, FEBS LETT, vol. 339, 1994, pages 285 - 290

Similar Documents

Publication	Publication Date	Title
GB201905780D0 (en)	2019-06-05	Cancer therapy
PL4190173T3 (en)	2025-01-07	Metabolic cancer therapy
IL300171A (en)	2023-03-01	Combined therapy against cancer
GB202301902D0 (en)	2023-03-29	Combination therapy for cancer
IL304436A (en)	2023-09-01	Cancer therapy
GB202103164D0 (en)	2021-04-21	Therapy
GB202001963D0 (en)	2020-04-01	Cancer therapy
GB202111035D0 (en)	2021-09-15	Therapy
GB202108303D0 (en)	2021-07-28	Therapy
GB202002639D0 (en)	2020-04-08	Therapy
GB202108828D0 (en)	2021-08-04	Novel cancer therapy
GB202000984D0 (en)	2020-03-11	Cancer therapy
GB202318158D0 (en)	2024-01-10	Cancer therapy
GB202302018D0 (en)	2023-03-29	Cancer therapy
GB202218395D0 (en)	2023-01-18	Cancer therapy
GB202212918D0 (en)	2022-10-19	Cancer therapy
GB202116680D0 (en)	2022-01-05	Combination therapy for cancer
GB202103673D0 (en)	2021-04-28	Combination therapy for cancer
GB202118025D0 (en)	2022-01-26	Cancer treatment
GB202111930D0 (en)	2021-10-06	Cancer treatment
GB202113791D0 (en)	2021-11-10	Novel therapy
GB202107825D0 (en)	2021-07-14	Novel therapy
GB202010314D0 (en)	2020-08-19	Cancer treatment
GB202108827D0 (en)	2021-08-04	Novel antibody cancer therapy
GB201901368D0 (en)	2019-03-20	Cancer therapy

Legal Events

Date	Code	Title	Description
2023-03-01	AT	Applications terminated before publication under section 16(1)